• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/44

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

44 Cards in this Set

  • Front
  • Back

Classes of Antidysrhythmic Drugs

Class I: sodium channel blockers- slow it down


Class II: beta blocker (block epinephirne and norepinephrine.


Class III: potassium channel blocker


Class IV: Calcium channel blockers- hear contracting too rapidly

Antidysrhthmic Drugs

An abnormality in the rhythm of the heartbeat.


Two basic types of dysrhythmias:


1. Tachydysrhythmias: heart rate is increased


2. Bradydysrhythmias: heart rate is slowed


- Dysrhythmias are also known as arrhythmias

Electrical properties of the heart

Impulse conduction: pathways and timing


SA node, AV node, His

SA node

pacemaker of heart


fires 60-100 times/minute

AV node

fires 40-60 times/minute

His-Purkinje system

Fires more than 40 times/minute

Cardiac action potentials

Occur in fibers of the His-Purkinje system and in atrial and ventricular muscle. There are 5 distinct phases: Phases 0, 1, 2, 3, and 4.

Phase 0

depolarization (resting)

Phase 1

(partial) repolarization

Phase 2

plateau

Phase 3

Repolarization (low cardiac output)


Phase 4

Stable potential

The electrocardiogram

P wave


QRS complex


T wave


PR interval


QT interval


ST segment

P wave

Depolarization in the atria. The current has traveled form AV node to atria

QRS complex

Depolarization of the ventricles.


Current going down bundle branches.

T wave

Repolarization of the ventricles.


Ventricular filling.

Gneration of Dysrhythmias

2 fundamental causes:


1. Disturbances of automaticity


2. Disturbances of conduction


-Atrioventricular block


Classification of Antidysrhythmic Drugs

Vaughan Williams Classification


Class 1: sodium channel blockers


Class 2: beta blockers


Class 3: potassium channel blockers


Class 4: Calcium channel blockers


Other: adenosine, digoxin, and ibutilide

Supraventricular dysrhythmias

Impuse arises above the ventricle


Atrial flutter


Atrial fibrillation


Sustained supraventricular tachycardia (SVT)

Multiple Varied P waves

Atrail fibrillation. Wavy baseline and irregular rhythm. The atria is quivering. It pools and clots in the atria.

Ventricular dysrhthmias

Sustained ventricular tachycardia


Ventricular fibrilation


Ventricular premature beats


Digoxin-induced ventricular dysrhythmias


Torsades de Pointes

No P wave

Ventricular fibrillation

Class I: Sodium channel Blockers

Treat atrial and ventricular dysrhythmias


Class IA agents: Quinidine


Class IB agents: Lidocaine

Quinidine: Effects on the heart

Blocks sodium channels


Slows impulse conduction


Delays repolarization

Quinidine: Effects on the ECG

Widens the QRS complex


Prolongs the QT interval


Slows the rhythm

Quinidine: Therapeutic uses

Used against supraventricular and ventricular dysrhthmias

Quinidine: Adverse Effects

Diarrhea


Cinchonsim


Cardiotoxicity


Atrerial embolism (due to atrial fibrilation)


Alpha-adrenergic blockade, resulting in hypotension


Hypersensitivity reactions


Drug interaction: Digoxin

Cinchonism

Tinnitus, H/A, nausea, vertigo, disturbed vision

Lidocaine (Xylocaine): Effects on the heart and ECG

Blocks cardiac sodium channels


Slows conduction in the atria, ventricles, and His-purkinje system


Reduces automaticity in the ventricles and His-Purkinje system

Lidocaine: Adverse effects

CNS effects


Drowsiness


Confusion


Paresthesias

Paresthesias

tingling and numbness in extremities

Class II Beta blockers

Propranolol (Inderal)


Carvedilol (Coreg)

Class II Beta Blockers: Propranolol (Inderal) and Carvedilol (Coreg): Effects on the heart and ECG

Decreased automaticity of the SA node


Decreased velocity of conduction through the AV node.


Decreased myocardial contractility: negative inotropic effect

Cass II Beta Blockers: Popranolo (inderal) and Carvedilol (Coreg) Therapeutic use

Dysrhythmias caused by excessive sympathetic stimulation


Supraventricular tachydysrhythmias: suppression of excessive discharge and slowing of heart rate

Class II Beta Blockers: Propranolol (Inderal) and Carvedilol (Coreg): Adverse Effects

Heart block


Heart failure


AV block


Sinus arrest


Hypotension


Bronchospasm (in asthma patients)

Class III: Potassium channel blockers- Amiodarone (Cordarone, Pacerone)


Therapeutic uses

Long term therapy for life-threatening ventricular dysrhythmias and converting atrial fibrilation to normal sinus rhythm.


Recurrent ventricular fibrilation


Recurrent hemodynamically unstable ventricular tachycardia

Class III: Potassium channel blockers: Amiodarone (Cordarone, Pacerone)


Effects on the heart and ECG

Reduces automaticity in the SA node


Reduced contractility


Reduced conduction velocity


QRS widening


Prolongation of the PR and QT intervals

Class III: Potassium Channel blockers: Amiodarone (Cordarone, Pacerone)


Adverse Effects

Pulmonary toxicity


Cardiotoxicity


Toxicity in pregnancy and breastfeeding


Corneal microdeposists


Optic neuropathy

Class III Potassium Channel Blockers: Amiodarone (Cordarone, Pcerone):


Drug Interactions

Quinidine


Diogoxin


Procainamide


Diltiazem


Phenytoin


Warfarin

Class IV: Calcium Channel Blockers: Verapamil and Diltiazem

Reduces SA nodal automaticity


Delays AV nodal conduction


Reduces myocardial contractility


Therapeutic uses:


1. Slows heart rate (atrial fibrilation or atrial flutter)


2. Terminate SVT caused by an AV nodal reentrant circuit

Class IV: Calcium Channel Blockers: Berapamil and Diltiazem Adverse Effects

Bradycardia


Hypotension


AV block


Heart failure


Peripheral edema


Constipation

Adenosine: Effects on the heart and ECG

Decreases automaticity in the SA node


Slows conduction through the AV node


Prolongation of PR interval

Adenosin: Therapeutic use

Termination of paroxysmal SVT

Adenosine: Adverse effects

Sinus bardycardia, possible asystole


Dyspnea


Hypotension


Facial flushing.